Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Janux Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 155
- +36 vs. Q1 2024
- Shares held
- 44.7M
- +2.41M (+5.7%) vs. Q1 2024
- Total value
- $1.87B
- +$279.9M (+17.6%) vs. Q1 2024
- New holders
- 55
- 58 more added
- Sold out
- 19
- 33 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Zacks Investment Management | 38,773 | $1.62M | 0.02% | −2,146−5.2% | Reduced |
| Jane Street Group, LLC | 39,566 | $1.66M | 0.00% | +19,434+96.5% | Added |
| Blue Owl Capital Holdings LP | 40,000 | $1.68M | 0.47% | +40,000 | New |
| Swiss National Bank | 40,700 | $1.70M | 0.00% | +8,900+28.0% | Added |
| Wellington Management Group LLP | 43,934 | $1.84M | 0.00% | +12,339+39.1% | Added |
| DekaBank Deutsche Girozentrale | 49,500 | $1.88M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 45,052 | $1.89M | 0.39% | −135,155−75.0% | Reduced |
| Ghost Tree Capital, LLC | 50,000 | $2.09M | 0.73% | +50,000 | New |
| UBS Group AG | 50,868 | $2.13M | 0.00% | +28,664+129.1% | Added |
| Voloridge Investment Management, LLC | 55,212 | $2.31M | 0.01% | +55,212 | New |
| Soleus Capital Management, L.P. | 55,500 | $2.32M | 0.21% | −102,300−64.8% | Reduced |
| EAM Investors, LLC | 55,618 | $2.33M | 0.38% | −355−0.6% | Reduced |
| Voya Investment Management LLC | 60,578 | $2.54M | 0.00% | +19,925+49.0% | Added |
| Tudor Investment Corp Et Al | 67,487 | $2.83M | 0.03% | +61,072+952.0% | Added |
| Macquarie Group Ltd | 76,601 | $3.21M | 0.00% | +16,601+27.7% | Added |
| Rafferty Asset Management, LLC | 77,246 | $3.24M | 0.01% | +77,246 | New |
| Charles Schwab Investment Management Inc | 77,516 | $3.25M | 0.00% | +28,258+57.4% | Added |
| Morgan Stanley | 81,798 | $3.43M | 0.00% | −39,433−32.5% | Reduced |
| StemPoint Capital LP | 92,949 | $3.89M | 1.15% | −28,693−23.6% | Reduced |
| D. E. Shaw & Co., Inc. | 97,823 | $4.10M | 0.01% | +43,185+79.0% | Added |
| Two Sigma Investments, LP | 103,601 | $4.34M | 0.01% | −121,119−53.9% | Reduced |
| Ratan Capital Management LP | 105,757 | $4.43M | 1.36% | +85,757+428.8% | Added |
| Rhenman & Partners Asset Management AB | 106,847 | $4.48M | 0.43% | +2,347+2.2% | Added |
| Candriam Luxembourg S.C.A. | 112,004 | $4.69M | 0.03% | +31,999+40.0% | Added |
| Bank of New York Mellon Corp | 115,027 | $4.82M | 0.00% | +66,340+136.3% | Added |
| Bank of America Corp | 119,395 | $5.00M | 0.00% | +95,854+407.2% | Added |
| Ensign Peak Advisors, Inc | 133,000 | $5.57M | 0.01% | +133,000 | New |
| Point72 Asset Management, L.P. | 136,430 | $5.72M | 0.02% | +136,430 | New |
| Northern Trust Corp | 194,373 | $8.14M | 0.00% | −7,610−3.8% | Reduced |
| Alyeska Investment Group, L.P. | 199,384 | $8.35M | 0.05% | +6,338+3.3% | Added |
| Artal Group S.A. | 203,000 | $8.50M | 0.22% | +153,000+306.0% | Added |
| Schonfeld Strategic Advisors LLC | 242,531 | $10.2M | 0.08% | +89,810+58.8% | Added |
| Price T Rowe Associates Inc | 252,358 | $10.6M | 0.00% | +232,762+1,187.8% | Added |
| Woodline Partners LP | 300,825 | $12.6M | 0.12% | +270,977+907.9% | Added |
| Samlyn Capital, LLC | 324,703 | $13.6M | 0.23% | +28,312+9.6% | Added |
| Goldman Sachs Group Inc | 344,672 | $14.4M | 0.00% | −2,499−0.7% | Reduced |
| Nuveen Asset Management, LLC | 396,906 | $16.6M | 0.00% | +318,281+404.8% | Added |
| BVF Inc | 441,528 | $18.5M | 0.52% | −2,478,290−84.9% | Reduced |
| Geode Capital Management, LLC | 624,104 | $26.1M | 0.00% | +156,557+33.5% | Added |
| Lord, Abbett & Co. LLC | 702,607 | $29.4M | 0.10% | +160,234+29.5% | Added |
| Vestal Point Capital, LP | 725,000 | $30.4M | 2.26% | +725,000 | New |
| Logos Global Management LP | 750,000 | $31.4M | 3.62% | +600,000+400.0% | Added |
| Avidity Partners Management LP | 840,219 | $35.2M | 1.50% | +455,974+118.7% | Added |
| Cormorant Asset Management, LP | 1,050,000 | $44.0M | 2.56% | +300,000+40.0% | Added |
| State Street Corp | 1,401,234 | $58.7M | 0.00% | +1,001,767+250.8% | Added |
| EcoR1 Capital, LLC | 1,469,818 | $61.6M | 1.89% | +1,469,818 | New |
| Citadel Advisors LLC | 1,557,116 | $65.2M | 0.06% | −793,122−33.7% | Reduced |
| Vanguard Group Inc | 1,561,758 | $65.4M | 0.00% | +203,798+15.0% | Added |
| Paradigm Biocapital Advisors LP | 1,564,452 | $65.5M | 2.51% | +1,564,452 | New |
| Janus Henderson Group PLC | 1,801,843 | $75.4M | 0.04% | −163,703−8.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,327,896 | $97.5M | 0.18% | −447,776−16.1% | Reduced |
| BlackRock Inc. | 2,344,007 | $98.2M | 0.00% | +650,016+38.4% | Added |
| OrbiMed Advisors LLC | 2,979,828 | $124.8M | 2.66% | −1,295,725−30.3% | Reduced |
| FMR LLC | 7,777,600 | $325.8M | 0.02% | +28,591+0.4% | Added |
| Ra Capital Management, L.P. | 9,165,652 | $383.9M | 5.08% | 00.0% | Unchanged |
| RTW Investments, LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −193,300−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −191,055−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −92,899−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −64,500−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −52,300−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −47,949−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −21,431−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −21,352−100.0% | Sold out |
| Discovery Capital Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −14,174−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −8,464−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −8,524−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,909−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −6,892−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,808−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −5,784−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,004−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |